Publications 2025

Massonnaud CR, Peiffer-Smadja N, Poignard P, Jamard S, Goehringer F, Danion F, Reignier J, de Castro N, Garot D, Lapique EL, Lacombe K, Tolsma V, Faure E, Malvy D, Staub T, Courjon J, Cazenave-Roblot F, Dyrhol Riise AM, Leturnier P, Martin-Blondel G, Roger C, Akinosoglou K, Vincent Le Moing, Piroth L, Sellier P et al. (2025)
Efficacy, safety, pharmacokinetics, immunogenicity, and serum neutralizing activity of AZD7442 (tixagevimab-cilgavimab) in hospitalized COVID-19 patients: long-term results from the DisCoVeRy trial
Clin Microbiol Infect (in press)
DOI 10.1016/j.cmi.2025.12.014, PubMed 41429349

Tunheim G, Baranowska-Hustad M, Lund-Johansen F, Fossum E, Bhandari S, Kukule L, Møller TKR, Vikse EL, Bekkevold T, Oftung F, Robertson AH, Næss LM (2025)
SARS-CoV-2 Infection With Alpha B.1.1.7 Virus Induced Higher Antibody Responses Than Earlier Non-VOC Variants During the First Waves of the COVID-19 Pandemic in Norway
APMIS, 133 (12), e70102
DOI 10.1111/apm.70102, PubMed 41376258

Stenlander C, Lindahl H, Wahren-Borgström E, Geier CB, Sediva A, Fevang B, Milito C, Varandas C, Roca-Oporto C, Pulvirenti F, Hodl I, Malkusova I, Rivière JG, Litzman J, Walter JE, Hanitsch LG, Neth O, Kralickova P, Miller R, Shaffren S, Silva SL, Katzenstein T, Martelius T, Steiner UC, Smith CIE et al. (2025)
Bronchiectasis, Low IgG Levels and Lack of Vaccination are Risk Factors for Covid-19 Hospitalization in X-linked Agammaglobulinemia - A Retrospective Multicenter Study
J Clin Immunol, 45 (1), 161
DOI 10.1007/s10875-025-01962-3, PubMed 41240154